Form 8-K · Current report
Tesla, Inc. 8-K, filed Jul 22, 2026
- Filed
- CIK
- 0001318605
- Accession no.
- 0001628280-26-049213
Summary
Tesla released its second-quarter 2026 financial results, reporting record Q2 vehicle deliveries of 480,126, total revenues of $28.236 billion, GAAP net income of $1.114 billion, and GAAP operating income of $398 million. The company said Cybercab began production at Gigafactory Texas, Robotaxi is live in seven major metros, and Tesla Semi remains on track for production this year.
Key points
- Tesla reported Q2 2026 total revenues of $28.236 billion, GAAP net income of $1.114 billion, and GAAP operating income of $398 million.
- Tesla reported record Q2 vehicle deliveries of 480,126 and total production of 451,758.
- Tesla said Cybercab began production at Gigafactory Texas, while Tesla Semi remains on track for production this year at its new Nevada factory.
- Tesla said Robotaxi launched in three Florida cities in July and is now live in seven major metros.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 22, 2026, Tesla, Inc. released its financial results for the quarter ended June 30, 2026 by posting its Second Quarter 2026 Update on its website. The full text of the update is attached hereto as Exhibit 99.1 and is incorporated herein by reference. This information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.